Electromed, Inc. (NYSE:ELMD - Free Report) - Roth Capital issued their FY2025 earnings estimates for shares of Electromed in a report issued on Monday, July 21st. Roth Capital analyst K. Bauser expects that the company will post earnings per share of $0.81 for the year. Roth Capital has a "Strong-Buy" rating on the stock. Roth Capital also issued estimates for Electromed's Q4 2025 earnings at $0.22 EPS, Q1 2026 earnings at $0.22 EPS, Q2 2026 earnings at $0.31 EPS, Q3 2026 earnings at $0.21 EPS, Q4 2026 earnings at $0.26 EPS, FY2026 earnings at $1.00 EPS and FY2027 earnings at $1.15 EPS.
Several other brokerages have also recently commented on ELMD. Wall Street Zen cut shares of Electromed from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 8th. B. Riley upgraded shares of Electromed to a "strong-buy" rating in a report on Thursday, May 15th.
Read Our Latest Stock Report on Electromed
Electromed Price Performance
Shares of ELMD traded up $0.18 during mid-day trading on Thursday, hitting $18.82. The company's stock had a trading volume of 30,244 shares, compared to its average volume of 87,323. Electromed has a fifty-two week low of $13.74 and a fifty-two week high of $35.56. The firm has a 50-day moving average price of $20.22 and a 200 day moving average price of $24.45. The stock has a market capitalization of $157.82 million, a price-to-earnings ratio of 25.09 and a beta of 0.41.
Hedge Funds Weigh In On Electromed
A number of institutional investors have recently modified their holdings of ELMD. Millennium Management LLC boosted its stake in shares of Electromed by 362.7% in the 1st quarter. Millennium Management LLC now owns 194,519 shares of the company's stock valued at $4,641,000 after purchasing an additional 152,480 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in Electromed by 261.0% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 114,579 shares of the company's stock worth $3,386,000 after acquiring an additional 82,839 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Electromed in the 4th quarter valued at approximately $1,760,000. Acadian Asset Management LLC boosted its holdings in shares of Electromed by 25.2% in the 1st quarter. Acadian Asset Management LLC now owns 267,975 shares of the company's stock valued at $6,388,000 after buying an additional 53,872 shares during the last quarter. Finally, Lazard Asset Management LLC boosted its position in Electromed by 19,860.8% during the fourth quarter. Lazard Asset Management LLC now owns 47,906 shares of the company's stock worth $1,415,000 after purchasing an additional 47,666 shares during the period. Institutional investors own 40.82% of the company's stock.
About Electromed
(
Get Free Report)
Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.
Further Reading
Before you consider Electromed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Electromed wasn't on the list.
While Electromed currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access